GoHealth Beheer

Beheer criteriumcontroles 1/4

De CEO GoHealth is Vijay Kotte, benoemd in Jun2022, heeft een ambtstermijn van 2.42 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 5.14M, bestaande uit 17.5% salaris en 82.5% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 5.24% van de aandelen van het bedrijf, ter waarde $ 16.00M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 1.8 jaar en 2.5 jaar.

Belangrijke informatie

Vijay Kotte

Algemeen directeur

US$5.1m

Totale compensatie

Percentage CEO-salaris	17.5%
Dienstverband CEO	2.4yrs
Eigendom CEO	5.2%
Management gemiddelde ambtstermijn	1.8yrs
Gemiddelde ambtstermijn bestuur	2.5yrs

Recente managementupdates

Recent updates

GoHealth: Turning The Corner On Operating Cash Flow

May 28

GoHealth, Inc. (NASDAQ:GOCO) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

May 10

Analyse CEO-vergoeding

Hoe is Vijay Kotte's beloning veranderd ten opzichte van GoHealth's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Jun 30 2024	n/a	n/a	-US$64m
Mar 31 2024	n/a	n/a	-US$67m
Dec 31 2023	US$5m	US$900k	-US$67m
Sep 30 2023	n/a	n/a	-US$127m
Jun 30 2023	n/a	n/a	-US$132m
Mar 31 2023	n/a	n/a	-US$146m
Dec 31 2022	US$10m	US$485k	-US$150m

Compensatie versus markt: De totale vergoeding ($USD 5.14M ) Vijay } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 2.40M ).

Compensatie versus inkomsten: De vergoeding van Vijay is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.

CEO

Vijay Kotte (46 yo)

2.4yrs

Tenure

US$5,141,874

Compensatie

Mr. Vijay Kumar Kotte serves as Chief Executive Officer & Director of GoHealth, Inc. from June 06, 2022. He served as Executive Vice President, Strategy & Corporate Development and Chief Solutions Officer...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Brandon Cruz	Co-Founder & Non-Executive Co-Chairman	4.8yrs	US$500.00k	0.069% $ 210.0k
Clinton Jones	Co-Founder & Non-Executive Co-Chairman	4.8yrs	US$500.00k	0.25% $ 770.8k
Vijay Kotte	CEO & Director	2.4yrs	US$5.14m	5.24% $ 16.0m
Michael Hargis	Chief Operating Officer	1.3yrs	US$2.20m	0.64% $ 2.0m
Brendan Shanahan	Chief Financial Officer	less than a year	geen gegevens	geen gegevens
Katherine M. O'Halloran	Chief Accounting Officer	1.6yrs	geen gegevens	0.035% $ 107.2k
John Shave	Vice President of Investor Relations	no data	geen gegevens	geen gegevens
Bradley Burd	Chief Legal Officer & Corporate Secretary	less than a year	geen gegevens	0.073% $ 222.6k
Stephen Moffat	Chief Marketing Officer	1.8yrs	geen gegevens	geen gegevens
Alison Moriarty	Chief People Officer	1.8yrs	geen gegevens	geen gegevens
Blair Kessler	Chief Commercial Officer	less than a year	geen gegevens	geen gegevens
Michael Kelley	Chief Actuary & SVP of Strategic Business Insights	2.2yrs	geen gegevens	geen gegevens

1.8yrs

Gemiddelde duur

46yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van GOCO wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 1.8 jaar), wat duidt op een nieuw team.

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Brandon Cruz	Co-Founder & Non-Executive Co-Chairman	4.8yrs	US$500.00k	0.069% $ 210.0k
Clinton Jones	Co-Founder & Non-Executive Co-Chairman	4.8yrs	US$500.00k	0.25% $ 770.8k
Vijay Kotte	CEO & Director	2.4yrs	US$5.14m	5.24% $ 16.0m
David Fisher	Independent Director	2.5yrs	US$525.00k	0.71% $ 2.2m
Jeremy Gelber	Independent Director	4.8yrs	geen gegevens	geen gegevens
Timothy Wheatley	Director	less than a year	geen gegevens	geen gegevens
Alexander Timm	Lead Independent Director	4.8yrs	US$399.99k	0.24% $ 725.5k
Abhiraj Modi	Director	less than a year	geen gegevens	geen gegevens
Karoline Hilu	Independent Director	1.8yrs	US$355.79k	0.12% $ 381.0k

2.5yrs

Gemiddelde duur

46yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van GOCO wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 2.5 jaar), wat duidt op een nieuw bestuur.

GoHealth Beheer

Beheer criteriumcontroles 1/4

Belangrijke informatie

Recente managementupdates

GoHealth, Inc. Appoints Brendan Shanahan as Chief Financial Officer, Effective October 14, 2024

Less than half of directors are independent

GoHealth, Inc. Announces Changes to Board of Directors

GoHealth, Inc. Announces Chief Financial Officer Changes

GoHealth, Inc. Announces Resignation of Jason Schulz as Treasurer

GoHealth, Inc., Annual General Meeting, Jun 12, 2024

Recent updates

GoHealth, Inc. to Report Q3, 2024 Results on Nov 07, 2024

New minor risk - Shareholder dilution

GoHealth, Inc. Appoints Brendan Shanahan as Chief Financial Officer, Effective October 14, 2024

GoHealth, Inc. (NasdaqCM:GOCO) completed the acquisition of e-TeleQuote Insurance, Inc.

New minor risk - Shareholder dilution

New minor risk - Shareholder dilution

GoHealth, Inc. (NasdaqCM:GOCO) entered into a purchase agreement to acquire e-TeleQuote Insurance, Inc.

New minor risk - Shareholder dilution

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

GoHealth, Inc. Provides Earnings Guidance for the Full Year 2024

New minor risk - Share price stability

GoHealth, Inc. to Report Q2, 2024 Results on Aug 08, 2024

New minor risk - Shareholder dilution

Less than half of directors are independent

GoHealth, Inc. Announces Changes to Board of Directors

New minor risk - Shareholder dilution

New minor risk - Share price stability

New minor risk - Market cap size

GoHealth, Inc. Announces Chief Financial Officer Changes

GoHealth, Inc. Announces Resignation of Jason Schulz as Treasurer

GoHealth: Turning The Corner On Operating Cash Flow

First quarter 2024 earnings released: US$0.95 loss per share (vs US$1.12 loss in 1Q 2023)

GoHealth, Inc., Annual General Meeting, Jun 12, 2024

GoHealth, Inc. to Report Q1, 2024 Results on May 09, 2024

Consensus revenue estimates fall by 18%

Robbins Geller Rudman & Dowd LLP Announces a Notice of Pendency and Proposed Settlement of Class Action in the GoHealth, Inc. Securities Litigation

New minor risk - Shareholder dilution

Full year 2023 earnings released: US$3.40 loss per share (vs US$17.72 loss in FY 2022)

GoHealth, Inc. to Report Q4, 2023 Results on Mar 14, 2024

Price target increased by 43% to US$20.00

GoHealth, Inc. to Report Q3, 2023 Results on Nov 09, 2023

Group of buyers cancelled the acquisition of remaining stake in GoHealth, Inc. (NasdaqCM:GOCO).

GoHealth, Inc. Provides Earnings Guidance for the Year 2023

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

GoHealth, Inc. to Report Q2, 2023 Results on Aug 10, 2023

Consensus EPS estimates fall by 17%

GoHealth, Inc. Announces Departure of Shane Cruz, the Current Chief Strategy Officer, Whose Employment Will Terminate as of June 30, 2023

Price target increased by 31% to US$14.02

Group of buyers submitted a non-binding proposal to acquire remaining stake in GoHealth, Inc. (NasdaqCM:GOCO) for approximately $330 million.

CEO & Director recently bought US$100k worth of stock

Consensus EPS estimates upgraded to US$3.74 loss

GoHealth, Inc. (NASDAQ:GOCO) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

First quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

GoHealth, Inc. Reiterates Earnings Guidance for the Year 2023

Consensus revenue estimates decrease by 15%, EPS upgraded

Full year 2022 earnings: EPS and revenues miss analyst expectations

Consensus EPS estimates fall by 34%

Consensus EPS estimates fall by 37%

Gohealth, Inc. Appoints Karolina Hilu as A Class III Director

Consensus forecasts updated

GoHealth, Inc. Receives Extension Notice from Nasdaq

Consensus forecasts updated

Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

High number of new and inexperienced directors

GoHealth, Inc. to Report Q3, 2022 Results on Nov 10, 2022

GoHealth stock jumps 11% premarket on $50M private investment

GoHealth, Inc. announced delayed 10-Q filing

Price target decreased to US$1.10

GoHealth, Inc. to Report Q2, 2022 Results on Aug 15, 2022

GoHealth, Inc. Appoints Shane Cruz as Chief Strategy Officer

GoHealth, Inc. Names Jason Schulz as Chief Financial Officer

High number of new and inexperienced directors

GoHealth, Inc. Announces Executive Changes

GoHealth, Inc. Provides Revenue Guidance for the Fiscal Year Ending December 31, 2022

GoHealth, Inc., Annual General Meeting, May 25, 2022

GoHealth, Inc. Announces the Resignation of Anita Pramoda from the Board of Directors

GoHealth, Inc. announced delayed annual 10-K filing

Consensus EPS estimates fall by 68%

GoHealth, Inc. Provides Earnings Guidance for the Fourth Quarter and Full-Year Ended December 31, 2021